Soy protein, soybean isoflavones and coronary heart disease risk: Where do we stand?

Bibliography

• Food and Drug Administration: Food labeling, health claims, soy protein, and coronary heart disease. Fed. Reg. 57, 699–733 (1999).
   Google Scholar
• Desroches S, Mauger JF, Ausman LM, Lichtenstein AH, Lamarche B: Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic men and women. J. Nutr. 134, 574–579 (2004).
   Google Scholar
• Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ: Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am. J. Clin. Nutr. 78, 123–30 (2003).
   Google Scholar
• Cuevas AM, Irribarra VL, Castillo OA, YanezMD, Germain AM: Isolated soy protein improves endothelial function in postmenopausal hypercholesterolemic women. Eur. J. Clin. Nutr. 57, 889–894 (2003).
   Google Scholar
• Wiseman H, O'Reilly JD, Adlercreutz H et al.: Isoflavone phytoestrogens consumed in soy decrease F[2]-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72, 395–400 (2000).
   Google Scholar
• Dewell A, Hollenbeck PL, Hollenbeck CB: Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J. Clin. Endocrinol. Metab. 91, 772–780 (2006).
   Google Scholar
• Nestel P: Role of soy protein in cholesterollowering: how good is it? Arterioscler. Thromb. Vasc. Biol. 22, 1743–1744 (2002).
   Google Scholar
• Kris-Etherton PM, West SG: Soy protein with or without isoflavones: in search of a cardioprotective mechanism of action. Am. J. Clin. Nutr. 81, 5–6 (2005).
   Google Scholar
• Sacks FM: Dietary phytoestrogens to prevent cardiovascular disease. Early promise unfulfilled. Circulation 111, 385–387 (2005).
   Google Scholar
• Sirtori CR, Arnoldi A, Johnson SK: Phytoestrogens: End of a tale? Ann. Med. 37, 423–438 (2005).
   Google Scholar
• Wu Z, Rodgers RP, Marshall AG: Characterization of vegetable oils: detailed compositional fingerprints derived from electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. J. Agric. Food Chem. 52, 5322–5328 (2004).
   Google Scholar
• Brouwer IA, Katan MB, Zock PL: Dietary linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a metaanalysis. J. Nutr. 134, 919–922 (2004).
   Google Scholar
• Meta-analysis comprised of five cohort studies showing that higher α-linolenic acid intake is associated with a lower risk of fatal coronary heart disease. The difference between high and low intakes was only 1.2 g/day.
   Google Scholar
• Holguin F, Tellez-Rojo MM, Lazo M et al.: Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127, 1102–1107 (2005).
   Google Scholar
• Wang C, Harris WS, Chung M et al.: n-3 Fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primaryand secondary-prevention studies: a systematic review. Am. J. Clin. Nutr. 84, 5–17 (2006).
   Google Scholar
• Rand WM, Pellett PL, Young VR: Metaanalysis of nitrogen balance studies for estimating protein requirements in healthy adults. Am. J. Clin. Nutr. 77, 109–127 (2003).
   Google Scholar
• U.S. Department of Agriculture. Modification of the Vegetable Protein Products Requirements for the National School Lunch Program, School Breakfast Program, Summer Food Service Program and Child and Adult Care Food Program. Federal Register 7 CFR Parts 210, 215, 220, 225 and 226, 12429–12442 (2000).
   Google Scholar
• Franke AA, Custer LJ, Wang W, Shi CY: HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc. Soc. Exp. Biol. Med. 217, 263–273 (1998).
   Google Scholar
• Murphy PA, Song T, Buseman G et al.: Isoflavones in retail and institutional soy foods. J. Agric. Food Chem. 47, 2697–2704 (1999).
   Google Scholar
• Kuiper GG, Carlsson B, Grandien K et al.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors and . Endocrinology 138, 863–870 (1997).
   Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B et al.: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263 (1998).
   Google Scholar
• Teede HJ, Dalais FS, McGrath BP: Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am. J. Clin. Nutr. 79, 396–401 (2004).
   Google Scholar
• Yildiz MF, Kumru S, Godekmerdan A, Kutlu S: Effects of raloxifene, hormone therapy, and soy isoflavone on serum highsensitive C-reactive protein in postmenopausal women. Int. J. Gynaecol. Obstet. 90, 128–133 (2005).
   Google Scholar
• Well-designed study showing that, unlike hormone therapy, neither genistein nor raloxifene increase C-reactive protein levels. Thus, despite having some estrogenlike properties estrogen and isoflavones often exert different biological effects.
   Google Scholar
• D ’Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F: The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet. Gynecol. Scand. 84, 474–477 (2005).
   Google Scholar
• An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC: Estrogen receptor : selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem. 276, 17808–17814 (2001).
   Google Scholar
• Margeat E, Bourdoncle A, Margueron R, Poujol N, Cavailles V, Royer C: Ligands Differentially modulate the protein interactions of the human estrogen receptors and . J. Mol. Biol. 326, 77–92 (2003).
   Google Scholar
• Kostelac D, Rechkemmer G, Briviba K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J. Agric. Food Chem. 51, 7632–7635 (2003).
   Google Scholar
• Brzezinski A, Adlercreutz H, Shaoul R et al.: Short-term effect of phytoestrogen-rich diet on postmenopausal women. Menopause 4, 89–94 (1997).
   Google Scholar
• Diel P, Geis RB, Caldarelli A et al.: The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression. Mol. Cell Endocrinol. 221, 21–32 (2004).
   Google Scholar
• Constantinou A, Huberman E: Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med. 208, 109–115 (1995).
   Google Scholar
• Sarkar FH, Li Y: Soy isoflavones and cancer prevention. Cancer Invest. 21, 744–757 (2003).
   Google Scholar
• Barnes S: Soy isoflavones – phytoestrogens and what else? J. Nutr. 134, S1225–S1228 (2004).
   Google Scholar
• Akiyama T, Ogawara H: Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201, 362–370 (1991).
   Google Scholar
• Akiyama T, Ishida J, Nakagawa S et al.: Genistein, a specific inhibitor of tyrosinespecific protein kinases. J. Biol. Chem. 262, 5592–5595 (1987).
   Google Scholar
• Constantinou A, Kiguchi K, Huberman E: Induction of differentiation and DNA strand breakage in human HL-60 and K- 562 leukemia cells by genistein. Cancer Res. 50, 2618–2624 (1990).
   Google Scholar
• Kim H, Peterson TG, Barnes S: Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am. J. Clin. Nutr. 68, S1418–S1425 (1998).
   Google Scholar
• Howes LG, Howes JB, Knight DC: Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas (2006).
   Google Scholar
• Messina M: Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr. Rev. 61, 117–131 (2003).
   Google Scholar
• Messina M, Ho S, Alekel DL: Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr. Opin. Clin. Nutr. Metab. Care 7, 649–658 (2004).
   Google Scholar
• Nestel P: Isoflavones: their effects on cardiovascular risk and functions. Curr. Opin. Lipidol. 14, 3–8 (2003).
   Google Scholar
• Messina M, Nagata C, Wu AH: Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer 55, 1–12 (2006).
   Google Scholar
• Only comprehensive review that estimates the soy protein and isoflavone intake of several Asian countries based on large surveys of individuals.
   Google Scholar
• Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM: Phytoestrogen intake and endometrial cancer risk. J. Natl Cancer Inst. 95, 1158–1164 (2003).
   Google Scholar
• Goodman-Gruen D, Kritz-Silverstein D: Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J. Nutr. 131, 1202–1206 (2001).
   Google Scholar
• de Kleijn MJ, van der Schouw YT, Wilson PW et al.: Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study [1–4]. J. Nutr. 131, 1826–1832 (2001).
   Google Scholar
• van Erp-Baart MA, Brants HA, Kiely M et al.: Isoflavone intake in four different European countries: the VENUS approach. Br. J. Nutr. 89(Suppl. 1), S25–S30 (2003).
   Google Scholar
• van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, Keinan-Boker L, Rimm EB, Grobbee DE: Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 111, 465–471 (2005).
   Google Scholar
• Boker LK, Van der Schouw YT, De Kleijn MJ, Jacques PF, Grobbee DE, Peeters PH: Intake of dietary phytoestrogens by Dutch women. J. Nutr. 132, 1319–1328 (2002).
   Google Scholar
• Wiseman H, Casey K, Bowey EA et al.: Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am. J. Clin. Nutr. 80, 692–699 (2004).
   Google Scholar
• Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J. Nutr. 132, 3577–3584 (2002).
   Google Scholar
• Excellent review of the evidence suggesting that individuals who possess the intestinal bacteria capable of converting the soybean isoflavone daidzein into equol are more likely to benefit from isoflavone exposure.
   Google Scholar
• Lampe JW: Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J. Nutr. 133(Suppl. 3), S956–S964 (2003).
   Google Scholar
• Watanabe S, Yamaguchi M, Sobue T et al.: Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J. Nutr. 128, 1710–1715 (1998).
   Google Scholar
• Arai Y, Uehara M, Sato Y et al.: Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 10, 127–135 (2000).
   Google Scholar
• Akaza H, Miyanaga N, Takashima N et al.: Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J. Clin. Oncol. 34, 86–89 (2004).
   Google Scholar
• Setchell KD, Cole SJ: Method of defining equol-producer status and its frequency among vegetarians. J. Nutr. 136, 2188–2193 (2006).
   Google Scholar
• Joy S, Siow RC, Rowlands DJ et al.: The isoflavone Equol mediates rapid vascular relaxation: Ca2+-independent activation of endothelial nitric-oxide synthase/Hsp90 involving ERK1/2 and Akt phosphorylation in human endothelial cells. J. Biol. Chem. 281, 27335–27345 (2006).
   Google Scholar
• Liu D, Jiang H, Grange RW: Genistein activates the 3’,5’-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 146, 1312–1320 (2005).
   Google Scholar
• Liu D, Homan LL, Dillon JS: Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5’-monophosphate-dependent mechanism. Endocrinology 145, 5532–5539 (2004).
   Google Scholar
• Nagano J, Kono S, Preston DL et al.: Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int. J. Cancer 86, 132–138 (2000).
   Google Scholar
• Sadowska-Krowicka H, Mannick EE, Oliver PD et al.: Genistein and gut inflammation: role of nitric oxide. Proc. Soc. Exp. Biol. Med. 217, 351–357 (1998).
   Google Scholar
• Arora A, Nair MG, Strasburg GM: Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356, 133–141 (1998).
   Google Scholar
• Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG: Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch. Biochem. Biophys. 360, 142–148 (1998).
   Google Scholar
• Borras C, Gambini J, Gomez-Cabrera MC et al.: Genistein, a soy isoflavone, upregulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFkappaB. Faseb J. 20, 2136–2138 (2006).
   Google Scholar
• Mahn K, Borras C, Knock GA et al.: Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. Faseb J. 19, 1755–1757 (2005).
   Google Scholar
• Hodges RE, Krehl WA, Stone DB, Lopez A: Dietary carbohydrates and low cholesterol diets: effects on serum lipids on man. Am. J. Clin. Nutr. 20, 198–208 (1967).
   Google Scholar
• Sirtori CR, Agradi E, Conti F, Mantero O, Gatti E: Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet 1, 275–277 (1977).
   Google Scholar
• Carroll KK, Giovannetti PM, Huff MW, Moase O, Roberts DC, Wolfe BM: Hypocholesterolemic effect of substituting soybean protein for animal protein in the diet of healthy young women. Am. J. Clin. Nutr. 31, 1312–1321 (1978).
   Google Scholar
• Sirtori CR, Descovich G, Noseda G: Textured soy protein and serum-cholesterol. Lancet 1, 149 (1980).
   Google Scholar
• Sirtori CR, Zucchi-Dentone C, Sirtori M et al.: Cholesterol-lowering and HDLraising properties of lecithinated soy proteins in type II hyperlipidemic patients. Ann. Nutr. Metab. 29, 348–357 (1985).
   Google Scholar
• Verrillo A, de Teresa A, Carandente Giarrusso P, La Rocca S: Soybean protein diets in the management of type II hyperlipoproteinaemia. Atherosclerosis 54, 321–331 (1985).
   Google Scholar
• Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333, 276–282 (1995).
   Google Scholar
• Erdman JW Jr: Control of serum lipids with soy protein. N. Engl. J. Med. 333, 313–315 (1995).
   Google Scholar
• Cullen P: Evidence that triglycerides are an independent coronary heart disease risk factor. Am. J. Cardiol. 86, 943–949 (2000).
   Google Scholar
• Boden WE: High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial. Am. J. Cardiol. 86, L19–L22 (2000).
   Google Scholar
• Gotto AM Jr: High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am. Heart J. 144, S33–S42 (2002).
   Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ et al.: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8–15 (1989).
   Google Scholar
• Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease. In: Federal Register. 64(206), 57699–57733 (1999).
   Google Scholar
• Messina M: Potential public health implications of the hypocholesterolemic effects of soy protein. Nutr. 19, 280–281 (2003).
   Google Scholar
• Erdman JW, Jr. Soy protein and cardiovascular disease: A statement for healthcare professionals from the nutrition committee of the AHA. Circulation 102, 2555–2559 (2000).
   Google Scholar
• Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M: Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113, 1034–1044 (2006).
   Google Scholar
• Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285, 2486–2497 (2001).
   Google Scholar
• Jenkins DJ, Kendall CW, Faulkner D et al.: A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51, 1596–604 (2002).
   Google Scholar
• research demonstrating that by using a combined dietary approach that includes soy protein, fruits and vegetables, soluble fiber, phytosterols and a low-saturated fat diet can lead to marked reductions in blood cholesterol.
   Google Scholar
• Jenkins DJ, Kendall CW, Marchie A et al. : Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am. J. Clin. Nutr. 81, 380–387 (2005).
   Google Scholar
• Gardner CD, Coulston A, Chatterjee L, Rigby A, Spiller G, Farquhar JW: The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults: a randomized trial. Ann. Intern. Med. 142, 725–33 (2005).
   Google Scholar
• Balk E, Chung M, Chew P et al.: Effects of soy on health outcomes. Evidence report/technology assessment No. 126 (prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290–02–0022.) AHRQ Publication No. 05-E024–2. Rockville, MD Agency for Healthcare Research and Quality; July (2005).
   Google Scholar
• Weggemans RM, Trautwein EA: Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur. J. Clin. Nutr. 57, 940–946 (2003).
   Google Scholar
• Zhan S, Ho SC: Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 81, 397–408 (2005).
   Google Scholar
• Large meta-analysis comprised of clinical trials published after 1995 that found an overall reduction in low-density lipoprotein cholesterol (LDLC) of approximately 5%.
   Google Scholar
• Zhuo XG, Melby MK, Watanabe S: Soy Isoflavone Intake Lowers Serum LDL Cholesterol: A Meta-Analysis of 8 Randomized Controlled Trials in Humans. J. Nutr. 134, 2395–2400 (2004).
   Google Scholar
• Gianazza E, Eberini I, Arnoldi A, Wait R, Sirtori CR: A proteomic investigation of isolated soy proteins with variable effects in experimental and clinical studies. J. Nutr. 133, 9–14 (2003).
   Google Scholar
• Duranti M, Lovati MR, Dani V et al.: The subunit from soybean 7S globulin lowers plasma lipids and upregulates liver -VLDL receptors in rats fed a hypercholesterolemic diet. J. Nutr. 134, 1334–1339 (2004).
   Google Scholar
• Lovati MR, Manzoni C, Gianazza E et al.: Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J. Nutr. 130, 2543–2549 (2000).
   Google Scholar
• Gardner CD, Messina M, Kiazand A, Morris JC, Varady A, Franke A: Effect of two types of soy milk and dairy milk on plasma lipids in hypercholesterolemic adults: a randomized trial. Presented at: Sixth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. Chicago, IL, USA, 30 October–2 November
   Google Scholar
• 92. Sirtori CR, Gianazza E, Manzoni C, Lovati MR, Murphy PA: Role of isoflavones in the cholesterol reduction by soy proteins in the clinic. Am. J. Clin. Nutr. 65, 166–167 (1997).
   Google Scholar
• Crouse JR 3rd, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159, 2070–2076 (1999).
   Google Scholar
• Yeung J, Yu TF: Effects of isoflavones (soy phyto-estrogens) on serum lipids: A metaanalysis of randomized controlled trials. Nutr. J. 2, 15 (2003).
   Google Scholar
• Fang N, Yu S, Badger TM: Comprehensive phytochemical profile of soy protein isolate. J. Agric. Food Chem. 52, 4012–4020 (2004).
   Google Scholar
• Anderson RL, Wolf WJ: Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 125, S581–S588 (1995).
   Google Scholar
• Lichtenstein AH, Jalbert SM, Adlercreutz H et al.: Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler. Thromb. Vasc. Biol. 22, 1852–1858 (2002).
   Google Scholar
• Nestel P, Cehun M, Chronopoulos A, DaSilva L, Teede H, McGrath B: A biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men. Eur. J. Clin. Nutr. 58, 403–408 (2004).
   Google Scholar
• Petri Nahas E, Nahas Neto J, De Luca L, Traiman P, Pontes A, Dalben I: Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 48, 372–380 (2004).
   Google Scholar
• Dewell A, Hollenbeck CB, Bruce B: The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J. Clin. Endocrinol. Metab. 87, 118–121 (2002).
   Google Scholar
• Hale G, Paul-Labrador M, Dwyer JH, Merz CN: Isoflavone supplementation and endothelial function in menopausal women. Clin. Endocrinol. (Oxf.) 56, 693–701 (2002).
   Google Scholar
• Honore EK, Williams JK, Anthony MS, Clarkson TB: Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil. Steril. 67, 148–154 (1997).
   Google Scholar
• Mortensen A, Pilegaard K, Frandsen H, Breinholt V: Effect of a soy supplement on spontaneous atherosclerosis in low density lipoprotein receptor knock out (LDLR -/--) mice. Asia. Pac. J. Clin. Nutr. 13, S102 (2004).
   Google Scholar
• Adams MR, Golden DL, Franke AA, Potter SM, Smith HS, Anthony MS: Dietary soy - conglycinin (7S globulin) inhibits atherosclerosis in mice. J. Nutr. 134, 511–516 (2004).
   Google Scholar
• Ni W, Tsuda Y, Sakono M, Imaizumi K: Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J. Nutr. 128, 1884–1889 (1998).
   Google Scholar
• Zhang X, Shu XO, Gao YT et al.: Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J. Nutr. 133, 2874–2878 (2003).
   Google Scholar
• Large prospective epidemiologic study showing that among postmenopausal Chinese women soy intake is associated with a marked reduction in risk of nonfatal myocardial infarction far beyond that possible from cholesterol reduction alone.
   Google Scholar
• Sasazuki S: Case-control study of nonfatal myocardial infarction in relation to selected foods in Japanese men and women. Jpn Circ. J. 65, 200–206 (2001).
   Google Scholar
• Nagata C: Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int. J. Epidemiol. 29, 832–836 (2000).
   Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143–3421 (2002).
   Google Scholar
• Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Lowdensity lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260, 1917–1921 (1988).
   Google Scholar
• Bjornheden T, Babyi A, Bondjers G, Wiklund O: Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 123, 43–56 (1996).
   Google Scholar
• Merz-Demlow BE, Duncan AM, Wangen KE et al.: Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71, 1462–1469 (2000).
   Google Scholar
• Wangen KE, Duncan AM, Xu X, Kurzer MS: Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 73, 225–231 (2001).
   Google Scholar
• Lamarche B, Lemieux I, Despres JP: The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab. 25, 199–211 (1999).
   Google Scholar
• Stamler R: Implications of the INTERSALT study. Hypertension 17, I16–I20 (1991).
   Google Scholar
• Rivas M, Garay RP, Escanero JF, Cia P Jr, Cia P, Alda JO: Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J. Nutr. 132, 1900–1902 (2002).
   Google Scholar
• Welty FK, Guida KA: Soy nuts lower systolic and diastolic blood pressure in hypertensive and normotensive menopausal women. American Heart Association Meeting (Abstract 3018) (2002).
   Google Scholar
• Yang G, Shu XO, Jin F et al.: Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am. J. Clin. Nutr. 81, 1012–1017 (2005).
   Google Scholar
• He J, Gu D, Wu X, Chen J, Duan X, Whelton PK: Effect of soybean protein on blood pressure: a randomized, controlled trial. Ann. Intern. Med. 143, 1–9 (2005).
   Google Scholar
• Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223–261 (1983).
   Google Scholar
• Chen K, Thomas SR, Keaney JF Jr: Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic. Biol. Med. 35, 117–132 (2003).
   Google Scholar
• Heinecke JW: Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler. Thromb. Vasc. Biol. 21, 1261–1264 (2001).
   Google Scholar
• Graf E, Eaton JW: Antioxidant functions of phytic acid. Free Radic. Biol. Med. 8, 61–69 (1990).
   Google Scholar
• Pratt DE: Water soluble antioxidant activity of soybeans. J. Food Sci. 37, 322–323 (1972).
   Google Scholar
• Pratt DE, Birac PM: Source of antioxidant activity of soybeans and soy products. J. Food Sci. 44, 1720–1722 (1979).
   Google Scholar
• Romijn A, Cuppett SL, Zeece MG, Parkhurst AM, Lee ML: Impact of soy protein isolates and specific fractions on rancidity development in a cooked, refrigerated beef system. J. Food Sci. 56, 188–190 (1991).
   Google Scholar
• Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA: Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 26, 63–70 (1997).
   Google Scholar
• Cao G, Sofic E, Prior RL: Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med. 22, 749–760 (1997).
   Google Scholar
• Chen H-M, Muramoto K, Yamauchi F: Structural analysis of antioxidative peptides from soybeans B-conglycinin. J. Agric. Food Chem. 43, 574–578 (1995).
   Google Scholar
• Chen H-M, Muramoto K, Yamauchi F, Nokihara K: Antioxidant activity of designed peptides based on the antioxidative peptide isolated from digests of a soybean protein. J. Agr. Food Chem. 44, 2619–2633 (1996).
   Google Scholar
• Chen HM, Muramoto K, Yamauchi F, Fujimoto K, Nokihara K: Antioxidative properties of histidine-containing peptides Designed from peptide fragments found in the digests of a soybean protein. J. Agric. Food Chem. 46, 49–53 (1998).
   Google Scholar
• Aoki H, Otaka Y, Igarashi K, Takenaka A: Soy protein reduces paraquat-induced oxidative stress in rats. J. Nutr. 132, 2258–2262 (2002).
   Google Scholar
• Takenaka A, Annaka H, Kimura Y, Aoki H, Igarashi K: Reduction of paraquat-induced oxidative stress in rats by dietary soy peptide. Biosci. Biotechnol. Biochem. 67, 278–283 (2003).
   Google Scholar
• Manzoni C, Duranti M, Eberini I et al.: Subcellular localization of soybean 7s globulin in hepg2 cells and ldl receptor up-regulation by its alpha’ constituent subunit. J. Nutr. 133, 2149–2155 (2003).
   Google Scholar
• Kanazawa T, Osanai T, Zhang XS et al.: Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J. Nutr. 125, S639–S646 (1995).
   Google Scholar
• Tikkanen MJ, Adlercreutz H: Dietary soyderived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem. Pharmacol. 60, 1–5 (2000).
   Google Scholar
• Ashton E, Ball M: Effects of soy as tofu vs meat on lipoprotein concentrations. Eur. J. Clin. Nutr. 54, 14–19 (2000).
   Google Scholar
• Jenkins DJ, Kendall CWC, Jackson C-J et al.: Effects of high and low-isoflavone soyfoods on blood lipid, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr. 76, 365–372 (2002).
   Google Scholar
• Jenkins DJ, Kendall CW, Vidgen E et al.: Effect of soy-based breakfast cereal on blood lipids and oxidized low- density lipoprotein. Metabolism 49, 1496–500 (2000).
   Google Scholar
• Jenkins DJ, Kendall CW, Garsetti M et al.: Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity – a controlled crossover trial. Metabolism 49, 537–543 (2000).
   Google Scholar
• Scheiber MD, Liu JH, Subbiah MT, Rebar RW, Setchell KD: Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8, 384–392 (2001).
   Google Scholar
• Stephenson TJ, Setchell KD, Kendall CW, Jenkins DJ, Anderson JW, Fanti P: Effect of soy protein-rich diet on renal function in young adults with insulin-dependent diabetes mellitus. Clin. Nephrol. 64, 1–11 (2005).
   Google Scholar
• Nestel PJ, Yamashita T, Sasahara T et al.: Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 17, 3392–3398 (1997).
   Google Scholar
• Samman S, Lyons Wall PM, Chan GS, Smith SJ, Petocz P : The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147, 277–283 (1999).
   Google Scholar
• Gardner-Thorpe D, O’Hagen C, Young I, Lewis SJ: Dietary supplements of soya flour lower serum testosterone concentrations and improve markers of oxidative stress in men. Eur. J. Clin. Nutr. 57, 100–106 (2003).
   Google Scholar
• Hazen SL, Heinecke JW: 3-Chlorotyrosine, a specific marker of myeloperoxidasecatalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99, 2075–2081 (1997).
   Google Scholar
• Davis JN, Kucuk O, Djuric Z, Sarkar FH. Soy isoflavone supplementation in healthy men prevents NF- B activation by TNF- in blood lymphocytes. Free Radic. Biol. Med. 30, 1293–1302 (2001).
   Google Scholar
• Djuric Z, Chen G, Doerge DR, Heilbrun LK, Kucuk O: Effect of soy isoflavone supplementation on markers of oxidative stress in men and women. Cancer Lett. 172, 1–6 (2001).
   Google Scholar
• Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA: Soy isoflavones modulate immune function in healthy postmenopausal women. Am. J. Clin. Nutr. 83, 1118–1125 (2006).
   Google Scholar
• Cesari M, Rossi GP, Sticchi D, P essina AC: Is homocysteine important as risk factor for coronary heart disease? Nutr. Metab. Cardiovasc. Dis. 15, 140–147 (2005).
   Google Scholar
• Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K: Soy product intake is inversely associated with serum homocysteine level in premenopausal Japanese women. J. Nutr. 133, 797–800 (2003).
   Google Scholar
• Hagemeister H, Scholz-Ahrens KE, Schulte-Coerne H, Barth CA: Plasma amino acids and cholesterol following consumption of dietary casein or soy protein in minipigs. J. Nutr. 120, 1305–1311 (1990).
   Google Scholar
• Le Leu RK, McIntosh GH, Young GP: Ability of endogenous folate from soy protein isolate to maintain plasma homocysteine and hepatic DNA methylation during methyl group depletion in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 4, 457–464 (1998).
   Google Scholar
• Gudbrandsen OA, Wergedahl H, Liaset B, Espe M, Berge RK: Dietary proteins with high isoflavone content or low methionineglycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br. J. Nutr. 94, 321–330 (2005).
   Google Scholar
• Jenkins DJ, Kendall CW, Connelly PW et al.: Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51, 919–924 (2002).
   Google Scholar
• Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B: Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24, 228–233 (2001).
   Google Scholar
• Puska P, Korpelainen V, Hoie LH, Skovlund E, Lahti T, Smerud KT: Soy in hypercholesterolaemia: a double-blind, placebo-controlled trial. Eur. J. Clin. Nutr. 56, 352–357 (2002).
   Google Scholar
• Puska P, Korpelainen V, Hoie LH, Skovlund E, Smerud KT: Isolated soya protein with standardised levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholesterolaemia: a double-blind, placebo-controlled trial of a yoghurt formulation. Br. J. Nutr. 91, 393–401 (2004).
   Google Scholar
• Tonstad S, Smerud K, Hoie L: A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am. J. Clin. Nutr. 76, 78–84 (2002).
   Google Scholar
• Lukaczer D, Deann JL, Lerman RH et al.: Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 22, 104–113 (2006).
   Google Scholar
• Roughead ZK, Hunt JR, Johnson LK, Badger TM, Lykken GI: Controlled substitution of soy protein for meat protein: effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J. Clin. Endocrinol. Metab. 90, 181–189 (2005).
   Google Scholar
• Hermansen K, Hansen B, Jacobsen R et al.: Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 59, 843–850 (2005).
   Google Scholar
• Reimann M, Dierkes J, Carlsohn A et al.: Consumption of soy isoflavones does not affect plasma total homocysteine or asymmetric dimethylarginine concentrations in healthy postmenopausal women. J. Nutr. 136, 100–105 (2006).
   Google Scholar
• Bonaa KH, Njolstad I, Ueland PM et al.: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354, 1578–1588 (2006).
   Google Scholar
• Lonn E, Yusuf S, Arnold MJ et al.: Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354, 1567–1577 (2006).
   Google Scholar
• Toole JF, Malinow MR, Chambless LE et al.: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. Jama 291, 565–575 (2004).
   Google Scholar
• Mora S, Ridker PM: Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) – can C-reactive protein be used to target statin therapy in primary prevention? Am. J. Cardiol. 97, A33–A41 (2006).
   Google Scholar
• Ridker PM: High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am. Heart J. 148, S19–S26 (2004).
   Google Scholar
• Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE: Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100, 713–716 (1999).
   Google Scholar
• Pradhan AD, Manson JE, Rossouw JE et al. : Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study. Jama 288, 980–987 (2002).
   Google Scholar
• Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O: Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. J. Clin. Endocrinol. Metab. 88, 5180–5185 (2003).
   Google Scholar
• Hall WL, Vafeiadou K, Hallund J et al.: Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am. J. Clin. Nutr. 82, 1260–1268 (2005).
   Google Scholar
• Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA: Positive effect of dietary soy in ESRD patients with systemic inflammation- -correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol. Dial. Transplant. 21, 2239–2246 (2006).
   Google Scholar
• McVeigh BL, Dillingham BL, Lampe JW, Duncan AM: Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am. J. Clin. Nutr. 83, 244–251 (2006).
   Google Scholar
• Colacurci N, Chiantera A, Fornaro F et al.: Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 12, 299–307 (2005).
   Google Scholar
• Hilpert KF, Kris-Etherton PM, West SG: Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J. Nutr. 135, 1075–1079 (2005).
   Google Scholar
• Li Z, Hong K, Saltsman P et al.: Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur. J. Clin. Nutr. 59, 411–418 (2005).
   Google Scholar
• Herrington DM, Brown WV, Mosca L et al.: Relationship between arterial stiffness and subclinical aortic atherosclerosis. Circulation 110, 432–437 (2004).
   Google Scholar
• Meyer BJ, Larkin TA, Owen AJ, Astheimer LB, Tapsell LC, Howe PR: Limited lipidlowering effects of regular consumption of whole soybean foods. Ann. Nutr. Metab. 48, 67–78 (2004).
   Google Scholar
• Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP: Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab. 86, 3053–6300 (2001).
   Google Scholar
• Hallund J, Bugel S, Tholstrup T et al.: Soya isoflavone-enriched cereal bars affect markers of endothelial function in postmenopausal women. Br. J. Nutr. 95, 1120–1126 (2006).
   Google Scholar
• Nestel P, Fujii A, Zhang L: An isoflavone metabolite reduces arterial stiffness and blood pressure in overweight men and postmenopausal women. Atherosclerosis (2006).
   Google Scholar
• Yamashita T, Sasahara T, Pomeroy SE, Collier G, Nestel PJ: Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 47, 1308–1314 (1998).
   Google Scholar
• Tsunoda N, Pomeroy S, Nestel P: Absorption in humans of isoflavones from soy and red clover is similar. J. Nutr. 132, 2199–2201 (2002).
   Google Scholar
• Nestel PJ, Pomeroy S, Kay S et al.: Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 84, 895–898 (1999).
   Google Scholar
• Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ: Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 23, 1066–1071 (2003).
   Google Scholar
• Bonetti PO, Lerman LO, Lerman A: Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23, 168–175 (2003).
   Google Scholar
• Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ: The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17b-Estradiol. Circulation 103, 258–262 (2001).
   Google Scholar
• Squadrito F, Altavilla D, Crisafulli A et al.: Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am. J. Med. 114, 470–476 (2003).
   Google Scholar
• Squadrito F, Altavilla D, Morabito N et al.: The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 163, 339–347 (2002).
   Google Scholar
• First clinical trial to demonstrate that an isoflavone improves flow-mediated dilation. Also showed the mean baseline ratio of nitric oxide to endothelin significantly increased at the end of treatment.
   Google Scholar
• Yildirir A, Tokgozoglu SL, Oduncu T et al.: Soy protein diet significantly improves endothelial function and lipid parameters. Clin. Cardiol. 24, 711–716 (2001).
   Google Scholar
• Blum A, Lang N, Vigder F et al.: Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia. Clin. Invest. Med. 26, 20–26 (2003).
   Google Scholar
• Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT: Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am. J. Clin. Nutr. 81, 189–195 (2005).
   Google Scholar
• Simons LA, von Konigsmark M, Simons J, Celermajer DS: Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am. J. Cardiol. 85, 1297–1301 (2000).
   Google Scholar
• Lissin LW, Oka R, Lakshmi S, Cooke JP: Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc. Med. 9, 26–30 (2004).
   Google Scholar
• Pereira IR, Faludi AA, Aldrighi JM et al.: Effects of soy germ isoflavones and hormone therapy on nitric oxide derivatives, lowdensity lipoprotein oxidation, and vascular reactivity in hypercholesterolemic postmenopausal women. Menopause (2006).
   Google Scholar
• Teede HJ, Dalais FS, Kotsopoulos D et al. : Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women. J. Clin. Endocrinol. Metab. 90, 1936–1941 (2005).
   Google Scholar
• Cupisti A, Ghiadoni L, D’Alessandro C et al.: Soy protein diet improves endothelial dysfunction in renal transplant patients. Nephrol. Dial. Transplant. (2006).
   Google Scholar
• Evans M, Njike VY, Hoxley M, Pearson M, Katz DL: Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women. Menopause (2006).
   Google Scholar
• Law MR, Wald NJ, Thompson SG: By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br. Med. J. 308, 367–372 (1994).
   Google Scholar
• Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A: Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. Br. Med. J. 308, 363–366 (1994).
   Google Scholar
• Jenkins DJ, Kendall CW, Marchie A et al.: Effects of a dietary portfolio of cholesterollowering foods vs lovastatin on serum lipids and C-reactive protein. Jama 290, 502–510 (2003).
   Google Scholar
• Jones PH, Davidson MH, Stein EA et al.: Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am. J. Cardiol. 92, 152–160 (2003).
   Google Scholar
• Moreyra AE, Wilson AC, Koraym A: Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch. Intern. Med. 165, 1161–1166 (2005).
   Google Scholar
• Smit E, Nieto FJ, Crespo CJ, Mitchell P: Estimates of animal and plant protein intake in US adults: results from the Third National Health and Nutrition Examination Survey, 1988–1991. J. Am. Diet Assoc. 99, 813–820 (1999).
   Google Scholar
• Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW: Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 13, 831–839 (2006).
   Google Scholar
• Urban D, Irwin W, Kirk M et al.: The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J. Urol. 165, 294–300 (2001).
   Google Scholar
• Garrido A, De la Maza MP, Hirsch S, Valladares L: Soy isoflavones affect platelet thromboxane A2 receptor density but not plasma lipids in menopausal women. Maturitas 54, 270–276 (2006).
   Google Scholar
• Ishiwata N, Ueno T, Uschiyama S, Watanabe H: A randomized placebocontrolled trial of oral supplement for treatment of menopausal symptoms among Japanese women. Presented at: 4th International Soy and Health Conference. Düseldorf, Germany, 12–13 October
   Google Scholar